Clinical Data Highlight PlaCCine's Six-Month Durability, Temperature Stability, and Manufacturing Advantages Over mRNA Vaccines IMUNON Seeks Strategic Partner for PlaCCine® to Advance Novel Technology ...
Researchers unveil a groundbreaking DNA vaccine that supercharges immunity and boosts survival in patients with aggressive breast cancer—could this be the future of personalized cancer treatment?
The PharmaJet Needle-free Delivery System has shown effective uptake of the SCIB1 DNA vaccine in addition to offering speed, convenience, and enhanced patient experience. PharmaJet is eligible to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results